Oncofertility preservation in Mêda, Portugal: indication, cost and authorised clinics
Editorial guide to Oncofertility preservation in Mêda, Portugal: clinical indication, reference cost, CNPMA authorisation and patient steps. Source: SPMR – fertility preservation guidelines.
Oncofertility preservation (Portuguese: Preservação de fertilidade oncológica) is an advanced assisted-reproduction technique regulated in Portugal by the CNPMA under Lei n.º 32/2006. This page explains, for patients in Mêda (Guarda district, Centro), when Oncofertility preservation is appropriate, the reference price in Portugal, and where licensed centres operate. Urgent vitrification of oocytes or ovarian tissue before chemotherapy.
When Oncofertility preservation is indicated
Women and girls with cancer diagnosis prior to gonadotoxic therapy.
The clinical decision should follow a full work-up of the couple — history, semen analysis, ovarian reserve (AMH and antral follicle count) and review of prior cycles when applicable. In Mêda, this work-up can usually be done locally with subsequent referral to a CNPMA-authorised PMA centre. The request should include a written clinical justification: CNPMA requires technique-specific informed consent and SNS or insurance funding depends on this rationale.
Important clinical caveat: Free at SNS for cancer patients; random-start stimulation completes in 10–14 days. Covered by Lei n.º 32/2006. — use this to ask the clinic whether the indication is robust or whether the technique is being proposed routinely without evidence for your specific case.
Availability of Oncofertility preservation in Mêda
Mêda does not currently host a CNPMA-licensed embryology lab. For Oncofertility preservation, patients from the Centro region are typically referred to Guarda, where the licensed units cluster. Initial consultations and part of the monitoring can be done locally with results shared to the PMA centre.
This "local satellite + central lab" model is common in Portugal and aligns with ESHRE recommendations for decentralised access. Ask the clinic about logistics — how many in-person visits to the central site, whether monitoring is available in Mêda, and travel costs if applicable.
Cost of Oncofertility preservation (private and SNS)
This technique is typically free at the Portuguese SNS for eligible patients; private-sector costs depend on clinical indication.
At Portugal's SNS, CNPMA-authorised techniques are free for eligible patients — typically up to age 40, with clinical indication and no shared child with the same partner (technique-specific rules apply). Waiting lists at the most demanded public centres can reach 12–24 months. Medication is partially reimbursed via SNS prescription.
Privately, request a detailed written quote covering: medical fees, laboratory, medication, annual cryopreservation (if applicable), and cancellation/refund policy. You can use our proposal request tool to receive three comparable estimates without commitment. Transparency check: serious clinics email written quotes; refuse verbal-only proposals or any that condition pricing on a mandatory in-person consultation.
Safety, ethics and sources
Oncofertility preservation is subject to the same legal and ethical guarantees as all PMA techniques in Portugal: written informed consent before each act, second opinion, access to the medical record, and complaint rights with the Health Regulator (ERS). Gamete and embryo cryopreservation is capped at 3 renewable years and any gamete donation is anonymous by default (offspring may access non-identifying data at age 18).
Our editorial team verified this page against the primary source: SPMR – fertility preservation guidelines. We update content whenever CNPMA or ESHRE publish new technical guidance. See our methodology for the full verification process and our corrections page if you spot an inaccuracy.
Practical next steps
If you live in Mêda and are considering Oncofertility preservation: (1) book a consultation with a gynaecologist or PMA centre and bring recent hormonal results; (2) explicitly discuss clinical indication and alternatives; (3) compare at least three written proposals, ideally one SNS and two private; (4) verify the CNPMA authorisation specific to Oncofertility preservation; (5) read informed consent calmly, questioning clauses on supernumerary embryo disposition and annual cryopreservation fees.
To explore the parent treatment, see our Oncofertility preservation — overview page and the editorial directory of clinics in Guarda. For more FAQs, see our glossary and people also ask section.
Frequently asked questions
Can I have Oncofertility preservation in Mêda?
Mêda does not have an authorised PMA lab in the municipality. Consultations may be local, but Oncofertility preservation will be performed in Guarda or another licensed centre.
How much does Oncofertility preservation cost in Portugal?
This technique is typically free at the Portuguese SNS for eligible patients; private-sector costs depend on clinical indication. Pricing varies significantly between centres — always request a written quote.
Is Oncofertility preservation covered by the Portuguese SNS?
Yes, when CNPMA-authorised and the patient meets eligibility (age, clinical indication). Public waiting lists may reach 12–24 months.
Is Oncofertility preservation more effective than standard treatment?
Free at SNS for cancer patients; random-start stimulation completes in 10–14 days. Covered by Lei n.º 32/2006. Discuss the evidence for your specific case with your clinician.
What sources support this information?
This page cites SPMR – fertility preservation guidelines (https://www.spmr.pt) and the official CNPMA annual reports. Updated whenever new guidance is issued.
Fontes e autoridades
Conteúdo verificado com base em reguladores oficiais, sociedades científicas e legislação portuguesa.
- 1
- 2
- 3
- 4


